Replies to post #131704 on Bioelectronics Corp (BIEL)

[JustGoDeep]

Proof Biel is Profitable and Growing Exponentially

Updated numbers because we now know B. Braun has them wearing Actipatches pre-operation too.

At least 1 month and perhaps as many as 12 because the wait time can be a year for hip or knee replacement.

B.Braun just added at least 160,000 Actipatch Sales per Quarter.

Simply do the math on sales from last quarter then do the math on adding B. Braun

It is over 533% growth.

Clue: About 100% growth is enough to be profitable.

NHS (Government of the U.K. Paying for Actipatches) gets added to THAT percentage too. 300%, or more??

Germany kicks in shortly with about another 200,000 per quarter.

Total growth of about 1200% when Germany kicks in, and add NHS.

READ IY YOURSELF ---From Shareholder Update

------------------

From the Shareholder Update

Currently there are 80,000 procedures per year involving B Braun. The "fast-track" same day hip and knee replacements are being supported by hospital physiotherapy teams visiting the patient at home and communicating using a special wireless technology tablet. Upon hospital discharge, each patient will be given an ActiPatch medical device and a prescription for 6 additional devices to help accelerate recovery and mitigate the postoperative pain. A similar program is in development for spinal surgeries.

On an international level, B. Braun's 54,000 employees are in 60 countries and are separated into additional divisions for hospital care, surgical products, outpatient care, and home care services. It is anticipated that B. Braun's German Group will roll out the same day hip and knee replacement program in the next few months.

NHS! Government of the U.K. paying for Actipatches Estimate 300% Increase in Sales? HUGE

Oh and Mundipharma selling in 9 Major Countries HUGE

Oh and shortly Smart Insole Deal HUGE

130,000 New shelves Contracted for HUGE

ANDA, INC Selling in America HUGE

Performance Health Selling in America HUGE

Smart Insole Deal HUGE

Read the shareholder update in yellow stickies for more details.

Biel RATING: SUPER NO BRAINER!!

[Simpsonly]

Hey JGD - Best to keep in mind you are working numbers from patients only and potential ActiPatches, without factoring in any estimate of market penetration or usage of ActiPatch by that total patient group . . . so, your numbers "2 plus 1 plus 6 Actipatches for B. Braun U.K. a Year." and then built out to "Total is somewhere 1,440,000 and 3,420,000 a year by themselves." assumes a 100% penetration, which in my view is not realistic . . . .

I would estimate 3% would be highly profitable, 5% wonderful and 10% a rocket launch. Perhaps the addition of ActiPatch to the NHS insured Tariff, the scourge of pain drugs and the cost benefits will take penetration higher, but there is no existing model on the planet to help with estimating this. I would be very interested in your market penetration estimates, not optimistic, not pessimistic, just cautiously realistic . . . .thanks